Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Zydus Wellness Q3 profit rises 44 percent to Rs 36 crore

      Zydus Wellness Q3 profit rises 44 percent to Rs 36 crore

      Ruby Khatun Khatun9 Feb 2018 10:30 AM IST
      New Delhi: Consumer products firm Zydus Wellness reported 43.83% jump in consolidated net profit to Rs36.16 crore for the December quarter of the...
      Roche notches fresh win amid crowd of immunotherapy cocktails

      Roche notches fresh win amid crowd of immunotherapy cocktails

      Ruby Khatun Khatun9 Feb 2018 9:49 AM IST
      ZURICH: Roche’s Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker’s...
      Philippine lawyers sue Sanofi over dengue vaccine

      Philippine lawyers sue Sanofi over dengue vaccine

      Ruby Khatun Khatun9 Feb 2018 9:30 AM IST
      MANILA: A Philippine government agency filed a lawsuit against French drugmaker Sanofi demanding compensation for the parents of a 10-year-old girl...
      Spurious Calcimax 500 drug worth Rs 95,000 seized by Maharashtra FDA

      Spurious Calcimax 500 drug worth Rs 95,000 seized by Maharashtra FDA

      Ruby Khatun Khatun8 Feb 2018 4:54 PM IST
      Mumbai: In a raid last week Maharashtra FDA is reported to have seized spurious drugs from two different firms worth Rs 95,000 and a FIR was filed...
      New Clinical Trials Rules 2018 released, check out details

      New Clinical Trials Rules 2018 released, check out details

      Ruby Khatun Khatun8 Feb 2018 4:51 PM IST
      New Delhi: The Ministry of Health has released draft rules 2018 for Clinical trials that will be called as New Drugs and Clinical trials Rules, 2018...
      Lupins JV completes global trials for rheumatoid arthritis biosimilar

      Lupin's JV completes global trials for rheumatoid arthritis biosimilar

      Ruby Khatun Khatun8 Feb 2018 11:00 AM IST
      PUNE: Drug major Lupin said its joint venture with Japanese firm Yoshindo, YL Biologics, has completed global phase III trials of its Etanercept...
      ED in HC to cancel bail of businessman arrested in Rs 5,000 crore PMLA case

      ED in HC to cancel bail of businessman arrested in Rs 5,000 crore PMLA case

      Ruby Khatun Khatun8 Feb 2018 10:15 AM IST
      New Delhi: The Delhi High Court sought response of a Delhi-based businessman, arrested in a Rs 5,000 crore money laundering case, on a plea of the...
      Pfizers Xtandi delays prostate cancer spread in early stage disease

      Pfizer's Xtandi delays prostate cancer spread in early stage disease

      Ruby Khatun Khatun8 Feb 2018 9:45 AM IST
      Use of Xtandi in early-stage prostate cancer on top of standard hormone therapy reduced the risk of disease spreading or death by 71 percent compared...
      Gilead fourth quarter hepatitis C drug sales plummet, sees further slowdown

      Gilead fourth quarter hepatitis C drug sales plummet, sees further slowdown

      Ruby Khatun Khatun8 Feb 2018 9:30 AM IST
      Gilead Sciences Inc said fourth-quarter sales of its flagship hepatitis C drugs fell by more than half amid increased competition, and the company...
      IHH Healthcare, Temasek looking to acquire majority stake in Medanta: Report

      IHH Healthcare, Temasek looking to acquire majority stake in Medanta: Report

      Ruby Khatun Khatun7 Feb 2018 4:48 PM IST
      New Delhi: IHH Healthcare Behard and Temasek Holding seem to be in the race to acquire a controlling stake in Medanta hospital recent media reports...
      Torrent Pharma and Brazils EMS vying for Sanofis generic drugs: sources

      Torrent Pharma and Brazil's EMS vying for Sanofi's generic drugs: sources

      Ruby Khatun Khatun7 Feb 2018 10:45 AM IST
      LONDON/FRANKFURT: Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit,...
      Lupin Q3 net profit dips 65 percent to Rs 222 crore

      Lupin Q3 net profit dips 65 percent to Rs 222 crore

      Ruby Khatun Khatun7 Feb 2018 10:17 AM IST
      New Delhi: Drug firm Lupin reported 64.97 percent fall in consolidated net profit at Rs 221.73 crore for the quarter ended December 31, mainly on...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok